Blood test for early detection of pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old
- You have been diagnosed with pancreatic cancer or a non-cancerous pancreatic condition (like chronic pancreatitis or a cyst)
- You have not had any previous treatment for your pancreatic condition (such as surgery, chemotherapy, or radiation)
- You do not have a history of other cancers or a recent severe infection
- You are willing to provide a blood sample and follow study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find new ways to detect liver, bile duct, and pancreatic cancers early using a blood test. It may help doctors diagnose these cancers sooner, when they are easier to treat.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This study looks for proteins in the blood that could help doctors tell the difference between pancreatic cancer and non-cancerous pancreatic conditions, such as chronic pancreatitis or benign cysts. By participating, you could help improve early and accurate diagnosis, which may lead to better outcomes for future patients.
This study uses a blood test to look at how your immune system responds, which may help tell if chronic pancreatitis could turn into pancreatic cancer. It aims to find better ways to monitor people with chronic pancreatitis and catch cancer earlier.
This trial studies a blood test to find pancreatic cancer early. It may help people who are at risk or have suspicious signs.
This trial studies whether a blood-based test can help detect pancreatic cancer (or strong signs of it) earlier than usual. The goal is to see how well “liquid biopsy” results match real diagnoses and risk levels.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.